Medivir to present at Swiss Nordic Bio in Zürich on March 7

STOCKHOLM, March 6, 2024 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer ... Read more

Bron:

Health